Fundraising Fox

Carlos Castro Gonzalez

Founder

Chief Executive Officer at Leuko Labs

Greater Boston

FoundedLeuko Labs

About

Carlos Castro Gonzalez is co-founder and CEO of Leuko, an MIT spinout developing PointCheck, a device intended to monitor white blood cell levels non-invasively in cancer patients undergoing therapy. He holds a PhD in Biomedical Engineering from the Technical University of Madrid and completed a postdoctoral fellowship at MIT, with prior work on AI algorithms for cardiac CT analysis and an ultrasound system for diagnosing infant meningitis. His recognitions include selection as an MIT Technology Review Innovator Under 35 and awards from MassChallenge HealthTech, Startup World Cup, the Rice Business Plan Competition, and NIH SBIR funding.

Chief Executive Officer at Leuko Labs

Intro paths

In turn, Carlos can intro founders to Leuko Labs's investors below.

Co-founders at Leuko Labs

IBIan Butterworth
Ian ButterworthChief Technology Officer
AB
Aurelien BourquardChief Data Scientist
AS
Alvaro Sanchez-FerroChief Medical Officer

Experience

  1. LeukoCo-Founder and CEOcurrent2018 — presentGreater Boston
  2. Massachusetts Institute of Technology (MIT)M+Vision Fellow2013 — 2018Boston, USA & Madrid, Spain
  3. Massachusetts Institute of Technology (MIT)Translational Fellow2014 — 2015Greater Boston
  4. Universidad Politécnica de MadridPostdoctoral Fellow2013Greater Madrid Metropolitan Area
  5. Universidad Politécnica de MadridPHD Fellow2008 — 2013Greater Madrid Metropolitan Area
  6. Universidad Politécnica de MadridResearch Engineer2007 — 2008Greater Madrid Metropolitan Area
  7. École PolytechniqueVisiting Scientist2010 — 2011Greater Paris Metropolitan Region
  8. Centre National de la Recherche Scientifique (CNRS)Visiting Scientist2009Greater Paris Metropolitan Region

Skills & more

Image ProcessingBiomedical EngineeringMachine Learning10Bioinformatics9Project Management8Life Sciences6Signal Processing7Medical Imaging5Microscopy4Data Analysis3Research3Entrepreneurship2
+10 moreGrant WritingAlgorithmsData ScienceResearch and Development (R&D)Start-upsBusiness StrategyTeam BuildingPattern RecognitionMatlabTeam Leadership

Languages English · French · Spanish

From Carlos's professional profile.

Frequently asked questions

Who is Carlos Castro Gonzalez?
Carlos Castro Gonzalez is co-founder and CEO of Leuko, an MIT spinout developing PointCheck, a device intended to monitor white blood cell levels non-invasively in cancer patients undergoing therapy. He holds a PhD in Biomedical Engineering from the Technical University of Madrid and completed a postdoctoral fellowship at MIT, with prior work on AI algorithms for cardiac CT analysis and an ultrasound system for diagnosing infant meningitis. His recognitions include selection as an MIT Technology Review Innovator Under 35 and awards from MassChallenge HealthTech, Startup World Cup, the Rice Business Plan Competition, and NIH SBIR funding.
Where does Carlos Castro Gonzalez work?
Carlos Castro Gonzalez is Chief Executive Officer of Leuko Labs.
What companies did Carlos Castro Gonzalez found?
Carlos Castro Gonzalez founded Leuko Labs.
Where did Carlos Castro Gonzalez go to school?
Carlos Castro Gonzalez studied at Universidad Politécnica de Madrid (PhD, Biomedical/Medical Engineering); KTH Royal Institute of Technology (MSc, Wireless Systems and Signal Processing); Universidad Politécnica de Madrid (BEng, Telecommunications Engineering).

Same school

Shared employers